Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of option activity

v3.22.2.2
Stockholders' Deficit (Details) - Schedule of option activity - Options [Member]
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Stockholders' Deficit (Details) - Schedule of option activity [Line Items]  
Option Number of Shares outstanding at beginning | shares 11,753,422
Option Weighted Average Exercise Price outstanding | $ / shares $ 0.36
Option Weighted Average Remaining Contractual Term outstanding at beginning 9 years 5 months 19 days
Option Aggregate Intrinsic Value outstanding at beginning | $ $ 196,825
Granted Number of Shares | shares 26,874,270
Granted Weighted Average Exercise Price | $ / shares $ 0.13
Granted Weighted Average Remaining Contractual Term 5 years
Granted Aggregate Intrinsic Value | $
Forfeited Number of Shares | shares (476,190)
Forfeited Weighted Average Exercise Price | $ / shares $ 0.21
Forfeited Weighted Average Remaining Contractual Term 9 years 2 months 12 days
Forfeited Aggregate Intrinsic Value | $
Exercised Number of Shares | shares
Exercised Weighted Average Exercise Price | $ / shares
Exercised Weighted Average Remaining Contractual Term
Exercised Aggregate Intrinsic Value | $
Expired Number of Shares | shares
Expired Weighted Average Exercise Price | $ / shares
Expired Weighted Average Remaining Contractual Term
Expired Aggregate Intrinsic Value | $
Option Number of Shares outstanding at ending | shares 38,151,502
Option Weighted Average Exercise Price outstanding at ending | $ / shares $ 0.2
Option Weighted Average Remaining Contractual Term outstanding at ending 6 years 1 month 24 days
Option Aggregate Intrinsic Value outstanding at ending | $
Option Number of Shares exercisable at ending | shares 35,344,654
Option Weighted Average Exercise Price exercisable at ending | $ / shares $ 0.2
Option Weighted Average Remaining Contractual Term exercisable at ending 5 years 11 months 23 days
Option Aggregate Intrinsic Value exercisable at ending | $